ONCY:NASDAQ
Oncolytics Biotech Inc
$0.63
arrow_downward
-1.59%(-0.010) 1D
$0.65
arrow_upward
+3.00% (+0.019)todayPre-market
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.65
High
$0.65
Low
$0.62
Mkt. cap
80.46M
Avg. vol.
969.28K
Volume
0.00
52-wk high
$1.42
52-wk low
$0.62
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.65
High
$0.65
Low
$0.62
Mkt. cap
80.46M
Avg. vol.
969.28K
Volume
0.00
52-wk high
$1.42
52-wk low
$0.62
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
FXLeaders
·
22 minutes ago
Dow Futures Lifted as Infrastructure & Data Center CapEx Spark Industrial Rally
www.marketscreener.com
·
49 minutes ago
Panmure Liberum sets 2027 year-end S&P 500 target at 5,000
TradingView
·
47 minutes ago
IXIC: Nasdaq Futures Flash Green as Traders Double Down on Risk. Rate-Hike Fear Is Fading
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com